Skip to content

Puri Safe Pharmaceuticals B.V.

Ongoing bankruptcy

Trading as Puri Safe

1 financial report
KvK
83342931
Establishment
Amsterdam, Noord-Holland
Sector
Not known
Court
Amsterdam
Bankruptcy number
F.13/24/169
Judgment
May 7, 2024

Summary

The Rechtbank Amsterdam declared Puri Safe Pharmaceuticals B.V. bankrupt on May 7, 2024 (insolvency number F.13/24/169). It concerns a BV with its place of establishment in Amsterdam (Noord-Holland). In the Dutch Commercial Register it has KvK number 83342931. It was founded on July 7, 2021. The company also used the trade name Puri Safe. The court appointed mr. W.P.Y. Overgoor of Addleshaw Goddard (Netherlands) LLP as insolvency practitioner. Supervision lies with supervisory judge mr. J.B. Oreel. There is 1 public report, dated October 5, 2026. In addition, there is 1 financial report, dated October 5, 2026. Estate assets according to financial report 10: €7,116.89. Key figures according to report 10: unsecured claims €103,888.83, creditors 4 en preferential claims €16,168. Status according to report 10: under investigation: sale of assets en director liability.

Over the past twelve months, 565 bankruptcies were declared in Noord-Holland. Of these, 241 were in the municipality of Amsterdam.

The company information lists Keizersgracht 520H, 1017EK Amsterdam as a business address for Puri Safe Pharmaceuticals B.V..

On January 2, 2025, the Dutch Insolvency Register published: “Vervanging rechter-commissaris mr. K.M. van Hassel door mr. J.B. Oreel.”

Submit a claim

Creditors submit their claim in writing to the insolvency practitioner, stating insolvency number F.13/24/169 and enclosing the supporting documents.

Deadline for submission
Not published
Estate assets Fin. report 10
€7,116.89, history of Estate assets
Unsecured claims Report 10
€103,888.83, history of Unsecured claims
Preferential Report 10
€16,168, history of Preferential
Creditors Report 10
4, history of Creditors

Not mentioned: employees

Further case information

Status

Rent and lease
Mentioned Rent and lease
Causes of the bankruptcy
Mentioned Causes of the bankruptcy
De Bestuurder heeft verklaard dat de oorzaak van het faillissement is gew eest dat Puri Safe een expediteur heeft ingeschakeld voor het transport van 1 goederen van de leveranciers in China naar het magazijn in Nederland. Met de expediteur w aren volgens de Bestuurder afspraken gemaakt over betaling na levering. De expediteur kreeg niet betaald en heeft de goederen niet afgeleverd, omdat zij vooru
Sale of assets
Under investigation Sale of assets
Collection of receivables
Mentioned Collection of receivables
Security rights
Mentioned Security rights
Restart (going-concern sale)
Mentioned Restart (going-concern sale)
Bookkeeping obligation
Mentioned Bookkeeping obligation
Filing of annual accounts
Completed Filing of annual accounts
Director liability
Under investigation Director liability
Actio pauliana
Mentioned Actio pauliana
Legal proceedings
Mentioned Legal proceedings
Lawfulness investigation
Under investigation Lawfulness investigation

Recent timeline

  1. Public report of October 5, 2026 published

  2. Public financial report of October 5, 2026 published

  3. Publication in the insolvency register

    Vervanging rechter-commissaris mr. K.M. van Hassel door mr. J.B. Oreel.

  4. Publication in the insolvency register

    Rectificatie: betreft F.13/24/169: Gelezen dient te worden: uitspraak faillissement op 8 mei 2024

  5. Publication in the insolvency register

    Uitspraak faillissement op 07 mei 2024

Key documents

  • Verslag: 05-10-2026

    10-05-2026 17 p. Rechtspraak

    View
  • Financieel verslag 05-10-2026

    10-05-2026 10 p. Rechtspraak

    View
  • Vervanging rechter-commissaris mr. K.M. van Hassel door mr. J.B. Oreel.

    01-02-2025 1 p. Central Insolvency Register

    View
  • Rectificatie: betreft F.13/24/169: Gelezen dient te worden: uitspraak faillissement op 8 mei 2024

    05-14-2024 1 p. Central Insolvency Register

    View

What you want to know about Puri Safe Pharmaceuticals B.V.

Who is the bankruptcy trustee of Puri Safe Pharmaceuticals B.V.?

The Rechtbank Amsterdam has appointed mr. W.P.Y. Overgoor of Addleshaw Goddard (Netherlands) LLP as bankruptcy trustee. For questions about the bankruptcy, please contact the bankruptcy trustee.

On what date did Puri Safe Pharmaceuticals B.V. go bankrupt?

Puri Safe Pharmaceuticals B.V. was declared bankrupt by the Rechtbank Amsterdam on May 7, 2024. The case has insolvency number F.13/24/169.

How do I report a claim against Puri Safe Pharmaceuticals B.V.?

Claims are sent in writing to the insolvency practitioner, mr. W.P.Y. Overgoor of Addleshaw Goddard (Netherlands) LLP. State insolvency number F.13/24/169 and enclose supporting documents, such as invoices and contracts.

How does the bankruptcy of Puri Safe Pharmaceuticals B.V. affect creditors?

In a bankruptcy the company may no longer dispose of its assets itself. The insolvency practitioner manages and sells the assets and distributes the proceeds among the creditors according to the statutory ranking. Whether and how much ordinary creditors receive usually only becomes clear at the end.

Are there public reports on the bankruptcy?

Yes, there is one public report, published on October 5, 2026. You can find it under Reports in this case.

Company details

Legal form
BV
Founded
July 7, 2021
KvK registration
Active
Special legal status
Bankruptcy
Trade names
Puri Safe

Sources

Not known: sbi code

Addresses

  • Business address Correspondence address Trading address
    Keizersgracht 520H 1017 EK Amsterdam
    • Built in 1905
    • woonfunctie
    • 70 m²